GENOMIC VISION S.A. EO-10

GENOMIC VISION S.A. EO-10

Action · FR0011799907 · A110TM (XPAR)
Aperçu
Analyse alimentée par l’IA
Analyse fondamentale
Découvrez ce que disent vraiment les chiffres — avant le marché
Analyser maintenant
Sentiment des actualités
Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?
Analyser maintenant
Acheter / Conserver / Vendre
Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.
Analyser maintenant
Évaluation des risques
Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.
Analyser maintenant
Juste valeur
Cette action est-elle bon marché, correctement valorisée ou surévaluée ?
Analyser maintenant
Dernières analyses d’IA sur GENOMIC VISION S.A. EO-10
Pas de cours
Flottant et Liquidité des Actions
Flottant Libre 26,52 %
Actions en Flottant 102,13 M
Actions en Circulation 385,11 M
Profil de l'entreprise pour GENOMIC VISION S.A. EO-10 Action
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.

Données de l'entreprise

Nom GENOMIC VISION S.A. EO-10
Société Genomic Vision S.A.
Site web https://www.genomicvision.com
Marché d'origine XPAR Paris
WKN A110TM
ISIN FR0011799907
Type de titre Action
Secteur Healthcare
Industrie Medical - Diagnostics & Research
PDG Aaron Bensimon
Pays France
Devise EUR
Employés 0,0 T
Adresse Green Square Batiment East, 92220 Bagneux
Date d'introduction en bourse 2014-04-02

Symboles boursiers

Nom Symbole
Paris GV.PA
Autres actions
Les investisseurs qui détiennent GENOMIC VISION S.A. EO-10 ont également les actions suivantes dans leur portefeuille :
Copenhagen Capital A/S
Copenhagen Capital A/S Action
YORKSH.WT.F. 25/33 MTN
YORKSH.WT.F. 25/33 MTN Obligation